Drew Angerer/Getty Images
- Bristol-Myers Squibb reported strong earnings on Friday, raising its full-year profit forecast.
- The company beat both sales and profit estimates in the second quarter.
- Shares spiked as much as 11% at intraday highs, the most since 2008.
Bristol-Myers Squibb's stock climbed as much as 11% on Friday, its biggest intraday surge since 2008, after beating profit forecasts and raising full-year guidance.
The drugmaker's second-quarter...